Camostat mesilate

甲磺酸卡莫司他

Report date: 2026/05/15 20:01:45
NME

Base Information

Drug NameCamostat mesilate
Drug Alias NameCamostat mesylate甲磺酸卡莫他特卡莫司他CamostatumFoipan +[6
ClassificationSmall molecules
Mechanisms of ActionProtease inhibitors
TargetsProtease
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)ObesityDiabetes Mellitus +[10
Global Approved IndicationsPancreatitis, ChronicEsophagitis, Peptic
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1985/08/01
Country/TerritoryBelgiumUnited StatesSweden +[8
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active IndicationsCoronavirus Disease 2019 (COVID-19)Pancreatitis, ChronicEsophagitis, Peptic +[4
Inactive IndicationsObesityDiabetes MellitusBlood Coagulation Disorders +[6

Other Information

ATC CodeB02AB04
Related LinksWikipediaKEGG